Vertex Pharmaceuticals Inc. buy Scotiabank
Start price
14.11.25
/
50%
€377.95
Target price
14.11.26
-
Performance (%)
7.67%
Price
26.02.26
€406.95
Summary
This prediction is currently active. With a performance of 7.67%, the BUY prediction by Scotiabank for Vertex Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 2.518% | 2.518% |
| iShares Core DAX® | 0.048% | 1.311% |
| iShares Nasdaq 100 | 1.601% | -0.902% |
| iShares Nikkei 225® | 3.057% | 12.947% |
| iShares S&P 500 | 0.820% | 0.703% |
Comments by Scotiabank for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Scotiabank for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€416.25
13.02.26
13.02.26
-
13.02.27
13.02.27
-2.23%
26.02.26
26.02.26
